U.S. Markets closed

Nufarm Limited (ASX:NUF) Might Not Be A Great Investment

Simply Wall St

Today we'll evaluate Nufarm Limited (ASX:NUF) to determine whether it could have potential as an investment idea. To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business.

First up, we'll look at what ROCE is and how we calculate it. Second, we'll look at its ROCE compared to similar companies. And finally, we'll look at how its current liabilities are impacting its ROCE.

Understanding Return On Capital Employed (ROCE)

ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business. Generally speaking a higher ROCE is better. Ultimately, it is a useful but imperfect metric. Renowned investment researcher Michael Mauboussin has suggested that a high ROCE can indicate that 'one dollar invested in the company generates value of more than one dollar'.

How Do You Calculate Return On Capital Employed?

Analysts use this formula to calculate return on capital employed:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Nufarm:

0.055 = AU$217m ÷ (AU$5.7b - AU$1.8b) (Based on the trailing twelve months to July 2019.)

Therefore, Nufarm has an ROCE of 5.5%.

Check out our latest analysis for Nufarm

Does Nufarm Have A Good ROCE?

When making comparisons between similar businesses, investors may find ROCE useful. We can see Nufarm's ROCE is meaningfully below the Chemicals industry average of 10%. This performance could be negative if sustained, as it suggests the business may underperform its industry. Setting aside the industry comparison for now, Nufarm's ROCE is mediocre in absolute terms, considering the risk of investing in stocks versus the safety of a bank account. Investors may wish to consider higher-performing investments.

Nufarm's current ROCE of 5.5% is lower than 3 years ago, when the company reported a 12% ROCE. Therefore we wonder if the company is facing new headwinds. You can click on the image below to see (in greater detail) how Nufarm's past growth compares to other companies.

ASX:NUF Past Revenue and Net Income, October 5th 2019

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. ROCE can be deceptive for cyclical businesses, as returns can look incredible in boom times, and terribly low in downturns. ROCE is only a point-in-time measure. Future performance is what matters, and you can see analyst predictions in our free report on analyst forecasts for the company.

Nufarm's Current Liabilities And Their Impact On Its ROCE

Short term (or current) liabilities, are things like supplier invoices, overdrafts, or tax bills that need to be paid within 12 months. Due to the way ROCE is calculated, a high level of current liabilities makes a company look as though it has less capital employed, and thus can (sometimes unfairly) boost the ROCE. To check the impact of this, we calculate if a company has high current liabilities relative to its total assets.

Nufarm has total assets of AU$5.7b and current liabilities of AU$1.8b. As a result, its current liabilities are equal to approximately 31% of its total assets. Nufarm's ROCE is improved somewhat by its moderate amount of current liabilities.

Our Take On Nufarm's ROCE

With this level of liabilities and a mediocre ROCE, there are potentially better investments out there. You might be able to find a better investment than Nufarm. If you want a selection of possible winners, check out this free list of interesting companies that trade on a P/E below 20 (but have proven they can grow earnings).

I will like Nufarm better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.